Advertisements

Global Blood Therapeutics Inc. (GBT) Stock Quote

Detailed Quote for Global Blood Therapeutics Inc. (GBT)
$ 32.55   0.55 (+1.72%) Volume: 674.18k 4:00 PM EDT Oct 20, 2017
After Hours:  $ 32.55 0.00 (0.00%) Volume: 32.32k 5:08 PM EDT Oct 20, 2017
Today 5d 1m 3m 1y more
Last Price
32.55
Change $
0.55
Change %
1.72%
Tick
  
Bid
26.00
Bid Size
400
Ask
33.30
Ask Size
800
Open
32.40
High
32.70
Low
31.50
Prev Close
32.00
Last Trade
10/20/17
Volume
674.18k
52 Wk Hi
41.1500015
52 Wk Low
13.3500003
Market Cap
1.42b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
43,676,804
EPS (TTM)
-2.49
PE Ratio
N/A
Exchange
NGS
News and Media for Global Blood Therapeutics Inc. (GBT)
Sector News | Topic News
News for Global Blood Therapeutics Inc. (GBT)
Thu, Oct 19, 2017
7:38 AM Your Daily Pharma Scoop: Gilead's Brave New World, AZN's Lynparza SNDA, RXDX Entrectinib Shows Positive Results - SeekingAlpha
Tue, Oct 17, 2017
4:28 AM Stellar BioSciences For Value Investors - SeekingAlpha
Sat, Oct 14, 2017
9:06 AM ROTY Volume 1 Edition 39: Tracking Performance And How To React To Weakness - SeekingAlpha
Thu, Oct 12, 2017
9:46 AM Your Daily Pharma Scoop: AcelRx DSUVIA PDUFA, Ardelyx Phase 3 Success, Rhopressa, LUXTURNA Adcomm Tomorrow - SeekingAlpha
Wed, Oct 11, 2017
1:50 PM A Current Breakdown Of The ROTY Model Account - SeekingAlpha
8:00 AM Global Blood Therapeutics Announces Presentation of New Data Showing Positive Effect of GBT440 on Sickle Cell Disease Patient with Variant Genotype - GlobeNewswire
Tue, Oct 03, 2017
5:38 PM After Hours Gainers / Losers - SeekingAlpha
1:21 PM ROTY Volume 1 Edition 35: Global Blood Therapeutics Setting Up, Zogenix\u00B4Offering And Trades - SeekingAlpha
8:01 AM Global Blood Therapeutics Announces Upcoming Presentations of GBT440 Data at Two Sickle Cell Disease Meetings in October - GlobeNewswire
Tue, Sep 26, 2017
4:05 PM Global Blood Therapeutics Announces New Employment Inducement Grants - GlobeNewswire
Thu, Sep 21, 2017
12:14 PM ROTY Volume 1 Edition 32: Learning From Mistakes And Additional Trades - SeekingAlpha
7:36 AM Premarket analyst action - healthcare - SeekingAlpha
Thu, Sep 07, 2017
8:20 AM ROTY Volume 1 Edition 28: Sarepta Shines And Several Holdings Waking Up - SeekingAlpha
Wed, Sep 06, 2017
8:02 AM Global Blood Therapeutics To Convene Sickle Cell Disease Influencers at\u00A0Annual Sickle Cell Disease (SCD) Therapeutics Conference - GlobeNewswire
Tue, Sep 05, 2017
3:18 PM Global Blood's GBT440 nabs Rare Pediatric Disease tag in U.S. - SeekingAlpha
1:47 PM FDA Approves Guerbet's Dotarem\u00AE (gadoterate meglumine) for Pediatric Patients Younger Than Two Years - PR Newswire
8:00 AM Global Blood Therapeutics Receives Rare Pediatric Disease Designation from FDA for GBT440 for Treatment of Sickle Cell Disease (SCD) - GlobeNewswire
Mon, Sep 04, 2017
4:59 AM Faison's Weekend Review And Scans - SeekingAlpha
Thu, Aug 31, 2017
1:52 PM ROTY Volume 1 Edition 25: Swapping Out Weakness For Strength - SeekingAlpha
Wed, Aug 30, 2017
4:05 PM Global Blood Therapeutics Announces Upcoming Participation in Multiple Investor Conferences in September - GlobeNewswire
More News for GBT >>

Tags for Global Blood Therapeutics Inc.

Research stocks or mutual funds related to Global Blood Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to GBT. The keywords below have been associated to GBT by either user submission or electronic means.